Artemis Medicare Services Ltd. (ARTEMISMED) Share Price Hits 52-Week High

Artemis Medicare Services Ltd. Share Price reached a fresh 52-week high of Rs 308, marking a 1.59% increase today. The company's market cap stands at Rs 4,388.25 crore.

Artemis Medicare Services Ltd. Share Price has reached a new 52-week high of Rs 308, reflecting a 1.59% increase from the previous close of Rs 299.1. The stock opened at Rs 301.15 and fluctuated between a low of Rs 300 and a high of Rs 308 during the trading session. With a market capitalisation of Rs 4,388.25 crore, this milestone highlights the company's growing investor interest. The healthcare sector, in which Artemis operates, has been a focal point for investors, contributing to the stock's upward momentum.

Artemis Medicare Services Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 303.85
Previous Close	Rs 299.1
Today's Change	+Rs 4.75 (+1.59%)
Day Open	Rs 301.15
Fresh 52-Week High	Rs 308
Day Low	Rs 300
Current Volume	9,765
Turnover	Rs 0.3 crore
Market Capitalisation	Rs 4,388.25 crore

Artemis Medicare Services Ltd. (ARTEMISMED) traded at Rs 303.85. versus the previous close of Rs 299.1, a rise of 1.59%. The stock opened at Rs 301.15, reached Rs 308, touched Rs 300. Reported volume was 9,765.

Today, Artemis Medicare Services Ltd. Share Price opened at Rs 301.15 and climbed to a high of Rs 308, setting a fresh 52-week high. The stock closed at Rs 303.85, up by Rs 4.75 or 1.59% from the previous close. The day's trading volume was 9,765 shares, with a turnover of Rs 0.3 crore, indicating moderate market participation. This price action suggests a positive sentiment among investors, possibly driven by the healthcare sector's overall performance.

Artemis Medicare Services Ltd. (ARTEMISMED) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 4,388.25 crore
P/E Ratio	30.28x
P/B Ratio	0.44x
ROE	-2.89%
ROCE	-0.26%

Artemis Medicare Services Ltd. was valued at a P/E ratio of 30.28x, a P/B ratio of 0.44x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	30.28x
Benchmark Median P/E	21.7x
Benchmark Average P/E	68.16x
Benchmark P/E Range	0x to 3,385.56x
Company P/B Ratio	0.44x
Benchmark Median P/B	1.9x
Company ROE	-2.89%
Benchmark Median ROE	10.73%
Company ROCE	-0.26%
Benchmark Median ROCE	13.2%
Company Market Capitalisation	Rs 4,388.25 crore
Benchmark Median Market Cap	Rs 138.42 crore

Artemis Medicare Services Ltd. (ARTEMISMED) is classified under sector: Healthcare.

Artemis Medicare Services Ltd. (ARTEMISMED) has a P/E ratio of 30.28x, which is above the benchmark median of 21.7x, a difference of +39.54%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Artemis Medicare Services Ltd. (ARTEMISMED) has a ROE of -2.89%, which is below the benchmark median of 10.73%, a difference of -126.93%. Artemis Medicare Services Ltd. (ARTEMISMED) has a ROCE of -0.26%, which is below the benchmark median of 13.2%, a difference of -101.97%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,856.59	30.28	0.44	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,686.76	40.11	8.17	28.21	26.35
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,432.22	34.7	7.02	-2.6	16.92
Sai Parenteral's Ltd.	SAIPARENT	2,415.06	171.06	3.16	13.9	12.97
Beta Drugs Ltd.	BETA	2,338.9	59.68	9.44	18.65	22.17

Artemis Medicare Services Ltd. (ARTEMISMED) has a P/E ratio of 30.28x compared with the displayed peer median of 40.11x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Artemis Medicare Services Ltd. (ARTEMISMED) has a market capitalisation of Rs 4,388.25 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Artemis Medicare Services Ltd.

• Reached a fresh 52-week high of Rs 308.
• Moderate trading volume and turnover.
• Valuation metrics suggest potential undervaluation.
• Operating within a competitive healthcare sector.
• Room for improvement in profitability ratios.

About Artemis Medicare Services Ltd.

Artemis Medicare Services Ltd. operates in the healthcare sector, providing a range of medical services. The company is known for its comprehensive healthcare offerings, including hospital and clinical services. As a key player in the healthcare industry, Artemis focuses on delivering quality medical care and expanding its service portfolio to meet growing healthcare demands.

Track Artemis Medicare Services Ltd. Share Price on Univest

Use Artemis Medicare Services Ltd. (ARTEMISMED) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors can track Artemis Medicare Services Ltd. Share Price, technical indicators, fundamental ratios, shareholding patterns, and market insights on Univest for comprehensive analysis and informed decision-making.

Frequently Asked Questions

What is the current share price of Artemis Medicare Services Ltd.?

Ans. The current share price of Artemis Medicare Services Ltd. is Rs 303.85, reflecting a 1.59% increase from the previous close of Rs 299.1. The stock moved 1.59% during the session.

What is the 52-week high of Artemis Medicare Services Ltd.?

Ans. Artemis Medicare Services Ltd. reached a fresh 52-week high of Rs 308, indicating strong investor interest in the stock. The stock moved 1.59% during the session. The intraday range extended from Rs 300 to Rs 308.

How does Artemis Medicare's P/E ratio compare to the sector?

Ans. Artemis Medicare's P/E ratio of 30.28 is above the sector median of 21.7 but below the average of 68.16, suggesting a balanced valuation. The company trades at a P/E ratio of 30.28x.

What is the market cap of Artemis Medicare Services Ltd.?

Ans. The market capitalisation of Artemis Medicare Services Ltd. is Rs 4,388.25 crore, positioning it as a significant player in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 30.28x.

How does Artemis Medicare's ROE compare to its peers?

Ans. Artemis Medicare's ROE of -2.89% is lower than peers like Kwality Pharmaceuticals Ltd., which has a positive ROE of 28.21%. ROE stands at -2.89%. ROCE stands at -0.26%. The relevant peer median ROE is 10.73%.

How does Artemis Medicare's P/B ratio compare to the sector?

Ans. Artemis Medicare's P/B ratio of 0.44 is significantly lower than the sector median of 1.9, indicating potential undervaluation. The company trades at a P/E ratio of 30.28x. Its P/B ratio is 0.44x.

What are the profitability challenges for Artemis Medicare?

Ans. Artemis Medicare faces profitability challenges with a negative ROE of -2.89% and ROCE of -0.26%, indicating areas for improvement. ROE stands at -2.89%. ROCE stands at -0.26%. The relevant peer median ROE is 10.73%.

Who are some of Artemis Medicare's peers?

Ans. Peers of Artemis Medicare include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Dr Agarwals Eye Hospital Ltd., among others. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Dr Agarwals Eye Hospital Ltd.